SPRO
Spero Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
SPRO fundamentals
Spero Therapeutics (SPRO) expects to report earnings on Aug 4, 2025, with estimated revenue of -- (YoY 0.00%), and EPS at -0.32 (YoY +3.03%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
-0.32
+3.03%
Report date
Aug 4, 2025
EPS
Revenue
Revenue & Expenses
SPRO has released its 2025 Q1 earnings report, with revenue of 5.87M, reflecting a YoY change of -36.61%, and net profit of -13.87M, showing a YoY change of -9.45%. The Sankey diagram below clearly presents SPRO's revenue sources and cost distribution.
Key Indicators
Spero Therapeutics (SPRO) key financial stats and ratios, covering profitability, financial health, and leverage.
Spero Therapeutics (SPRO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Spero Therapeutics (SPRO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Spero Therapeutics (SPRO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Spero Therapeutics (SPRO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Spero Therapeutics (SPRO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Spero Therapeutics year over year?What is Spero Therapeutics’s gross profit margin?Did Spero Therapeutics beat or miss consensus estimates last quarter?What does Spero Therapeutics do and what are its main business segments?What is Spero Therapeutics’s latest dividend and current dividend yield?What guidance did Spero Therapeutics’s management provide for the next earnings period? What were the key takeaways from Spero Therapeutics’s earnings call?What is the market’s earnings forecast for Spero Therapeutics next quarter?